Evidence map›Paper›PMID 33991483›Full record

ArticleThe Lancet. Public health2021

Addressing COVID-19 vaccine hesitancy: is official communication the key?

Michaël Schwarzinger, Stéphane Luchini

Abstract readComment
In one paragraph

Article in The Lancet. Public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Policies for Easing COVID-19 Pandemic Travel Restrictions.medRxiv : the preprint server for health sciences · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Michaël SchwarzingerDepartment of Methodology and Innovation in Prevention, Bordeaux University Hospital, 33000 Bordeaux, France; University of Bordeaux, Inserm UMR 1219-Bordeaux Population Health, Bordeaux, France. Electronic address: michael.schwarzinger@chu-bordeaux.fr.
Stéphane LuchiniAix-Marseille University, National Centre for Scientific Research (CNRS), School of Advanced Studies in the Social Sciences (EHESS), Ecole Centrale Marseille, Aix-Marseille School of Economics (AMSE), Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 VaccinesCommunicationHumansSARS-CoV-2Single-Blind MethodUnited KingdomVaccinationCOVID-19 Vaccines

Identifiers

PMID33991483
PMCPMC8116131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.